CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	May. 31, 2015	May. 31, 2014
Cash flows used in operating activities
Net Income (loss)	$ (464,879)	$ (1,444,895)
Changes to reconcile net loss to net cash used in operating activities
Consulting - Stock based compensation	177,596	941,154
MMJ expenses (recovery)	(576,000)	0
Gain on owned securities	(60,000)	(150,000)
Equity pick-up	0	132,781
Impairment of long term investments	6,270	76,595
Other non-cash activities	0	58,230
Change in non-cash working capital items:
Accounts receivable	540	(23,137)
Prepaid expenses and deposit	203,632	(251,670)
Inventory	(40,470)	0
Deferred charges	(30,000)	0
Accounts payable and accrued liabilities	(15,668)	(111,928)
Due to related parties	0	(50,700)
Net cash (used in) operating activities	(798,979)	(823,570)
Cash flows from (used in) investing activities
Investment in Pro Eco	0	10,004
Investment in Medical Marijuana Operations	0	(975,000)
Net cash from (used in) investing activities	0	(964,996)
Cash flows from financing activities
Promissory notes - related party	0	(47,380)
Net Proceeds from Options exercised	0	130,000
Net Proceeds from Warrants exercised	0	913,096
Net proceeds from subscriptions received	98,237	2,007,408
Net cash from financing activities	98,237	3,003,124
Increase (Decrease) in cash and cash equivalents	(700,742)	1,214,558
Cash and cash equivalents, beginning of period	888,122	1,341
Cash and cash equivalents, end of period	187,380	1,215,899
Supplemental information of cash flows
Interest paid in cash	0	0
Income taxes paid in cash	$ 0	$ 0